Iren Ltd
4 nominees · 10 ballot items.
Ten proposals are up for vote at the IREN Limited AGM, encompassing constitutional amendments to align quorum with Nasdaq rules, provide for director elections, add a forum selection provision, update universal proxy advance notice provisions, implement miscellaneous constitution changes, approve IREN's 2025 Omnibus Incentive Plan, authorize repurchases of ordinary shares via Prepaid Forward and Capped Call Transactions, and hold advisory votes on executive compensation and the frequency of future such votes.
Follow how the vote landed and what changed on Iren Ltd’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot10
- 1
Approve an amendment to IREN’s constitution to align the quorum requirement to conduct shareholder meetings with Nasdaq rules
ManagementBoard: FORAmends the Constitution to require a quorum of at least 33 1/3% of voting rights (including B Class shares) to hold a meeting or adjourned meetings, aligning with Nasdaq Rule 5620(c).
- 2
Approve an amendment to IREN’s constitution to provide for director elections at each annual general meeting
ManagementBoard: FORAdds a new rule structure to elect Non-Founder Directors at each AGM, under a classified board with sunset provisions and continuity benefits.
- 3
Approve an amendment to IREN’s constitution to add a forum selection provision
ManagementBoard: FORImplements exclusive forum for NSW courts for derivative and fiduciary-duty claims, and U.S. federal court for Securities Act claims, to reduce forum-shopping and consolidate litigation.
- 4
Approve an amendment to IREN’s constitution to update the advance notice provisions for universal proxies
ManagementBoard: FORUpdates provisions to align with Rule 14a-19 universal proxies, allowing nominations that comply with SEC rules and enabling IREN to disregard noncompliant nominations.
- 5
Approve amendments to IREN’s constitution to implement miscellaneous changes
ManagementBoard: FORUpdates to Definitions, references to Securities Laws, general meeting business, and section numbering across amendments; alignment with foreign issuer status.
- 6
Approve IREN’s 2025 Omnibus Incentive Plan
ManagementBoard: FORProposal to adopt the 2025 Omnibus Incentive Plan to replace the 2023 LTIP and govern employee, director and consultant awards; includes share pool and various award types.
- 7
Approve the repurchase by IREN of its ordinary shares pursuant to the Prepaid Forward Transactions
ManagementBoard: FORApprove selective buyback of up to 14,519,103 ordinary shares under Prepaid Forward Transactions with Citi; allows settlement in shares or cash; excludes certain selling shareholders from voting.
- 8
Approve the repurchase by IREN of its ordinary shares pursuant to the Capped Call Transactions
ManagementBoard: FORApprove selective buyback of up to 66,507,881 ordinary shares under Capped Call Transactions; enables settlement in shares or cash; aims to manage dilution related to convertible notes.
- 9
Approve an advisory vote on executive compensation (the “say-on-pay” vote
ManagementBoard: FORAdvisory vote on the compensation of the NEOs for fiscal 2025, as disclosed in the Proxy Statement.
- 10
Approve an advisory vote on the frequency of future advisory votes on executive compensation
ManagementBoard: FORAdvisory vote on how often IREN should seek future say-on-pay votes (every year, every two years, every three years, or abstain); board recommends every year.
Nominees on the ballot4
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Defiance ETFs, LLC | 3.5% | 12,671,028 | $434M |
| 2 | Situational Awareness Partners LP | 3.3% | 11,698,835 | $401M |
| 3 | Situational Awareness LP | 3.3% | 11,698,835 | $401M |
| 4 | CITIGROUP INC | 3.0% | 10,827,682 | $371M |
| 5 | BIT Capital GmbH | 1.8% | 6,527,102 | $224M |
| 6 | D. E. Shaw Co., Inc.Activist | 1.8% | 6,433,607 | $221M |
| 7 | GOLDMAN SACHS GROUP INC | 1.5% | 5,466,157 | $187M |
| 8 | Value Aligned Research Advisors, LLC | 1.3% | 4,767,607 | $163M |
| 9 | Marex Group plc | 1.1% | 3,826,244 | $131M |
| 10 | CANTOR FITZGERALD, L. P. | 0.8% | 2,937,510 | $101M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Iren Ltd’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Iren Ltd 2025 annual meeting?
- Iren Ltd (IREN) holds its 2025 annual shareholder meeting on Wednesday, November 19, 2025.
- What is the record date for the Iren Ltd 2025 meeting?
- The record date for the Iren Ltd 2025 meeting is Monday, September 29, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Iren Ltd's 2025 meeting?
- The board is presenting 4 director nominees at the Iren Ltd 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Iren Ltd 2025 meeting?
- Shareholders will vote on 10 proposals at the Iren Ltd 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.